RevvityRVTY
NYSELaboratory Instruments
No cached AI snapshot yet for RVTY.
Be the first to run a multi-agent analysis on this ticker.
Key Stats
11,000 employees111.80M shares outstandinglisted 1972-06-01dividend yield 0.33%
Next earnings ~May 2, 2026 · Ex-dividend Apr 17, 2026 · Dividend $0.07 quarterly
About Revvity
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
Latest News
Revvity extends gains with another 9% advance, sets new high
Revvity, Inc. (RVTY) Presents at 2026 Global Healthcare Conference Transcript
Revvity at 2026 Global Healthcare Conference: growth, AI and backlog
Revvity, Inc. (RVTY) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Revvity at Morgan Stanley conference: AI, margins and growth
FOMC preview: Rate hike priced in as markets await policy guidance
Related Stocksin Laboratory Instruments
Ready to see the live AI view on RVTY?
Launch a real-time multi-agent room — Claude, GPT, Gemini, DeepSeek, Grok, and Qwen analyzing RVTY side-by-side with live signals.